Drago R. Sliskovic

Matrix Metalloproteinase Inhibition Attenuates Left Ventricular Remodeling and Dysfunction in a Rat Model of Progressive Heart Failure

Janet T. Peterson, Hussein Hallak, Linda K. Johnson et al. · Circulation · 2001 · 301 citations

Inhibitors of cholesterol biosynthesis. 3. Tetrahydro-4-hydroxy-6-[2-(1H-pyrrol-1-yl)ethyl]-2H-pyran 2-one inhibitors of HMG-CoA reductase. 2. Effects of introducing substituents at positions three and four of the pyrrole nucleus

Bruce D. Roth, C. John Blankley, Alexander Chucholowski et al. · Journal of Medicinal Chemistry · 1991 · 183 citations · Full text

Structure−Activity Relationships and Pharmacokinetic Analysis for a Series of Potent, Systemically Available Biphenylsulfonamide Matrix Metalloproteinase Inhibitors

Patrick O’Brien, Daniel F. Ortwine, A.G. Pavlovsky et al. · Journal of Medicinal Chemistry · 2000 · 97 citations · Full text

Pharmaceutical Science, Bioorganic Chemistry, Effective Mmp Inhibitors +19

Inhibitors of Acyl-CoA:Cholesterol <i>O</i>-Acyl Transferase (ACAT) as Hypocholesterolemic Agents. CI-1011:  An Acyl Sulfamate with Unique Cholesterol-Lowering Activity in Animals Fed Noncholesterol-Supplemented Diets

Helen T. Lee, Drago R. Sliskovic, Joseph A. Picard et al. · Journal of Medicinal Chemistry · 1996 · 93 citations

Lipid Disorder, Acyl Sulfamate, Biochemistry +13

Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: Comparison with selected HMG-CoA reductase inhibitors

Thomas Bocan, Erika Ferguson, W. McNally et al. · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 1992 · 86 citations

Nonhepatic Sterol Synthesis, Hmg-coa Reductase Inhibitors, Hepatology +11